½ÃÀ庸°í¼­
»óǰÄÚµå
1519397

¼¼°èÀÇ °³ÀÎ ½Äº° ½ÃÀå º¸°í¼­ : Á¦Ç° ¹× ¼­ºñ½ºº°, ±â¼úº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°(2024-2032³â)

Human Identification Market Report by Product & Service, Technology, Application, End User, and Region 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 143 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è °³ÀÎ ½Äº° ½ÃÀå ±Ô¸ð´Â 2023³â 19¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ½ÃÀåÀÌ 2032³â±îÁö 49¾ï ´Þ·¯¿¡ À̸£°í, 2024-2032³â »çÀÌ¿¡ 10.7%ÀÇ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù.

°³ÀÎ ½Äº°Àº µ¥¿Á½Ã¸®º¸ÇÙ»ê(DNA) »ùÇÃÀ» °³ÀÎ ½Äº° ¹× ¹ýÀÇÇÐ ¼ö»ç¸¦ À§ÇØ ºÐ¼®ÇÏ´Â µ¥ »ç¿ëµÇ´Â ±â¼úÀ» ¸»ÇÕ´Ï´Ù. ÀÔ¼ú, ¾ó±¼, ¸Ó¸®, ¾î±ú, Áö¹®, ¼Õ¹Ù´ÚÀÇ °ËÃâÀ» µ½´Â ½Åü ºÎÀ§ °ËÃâ±â·Î ±¸¼ºµË´Ï´Ù. ¶ÇÇÑ Â÷¼¼´ë ½ÃÄö½Ì(NGS), ¸ð¼¼°ü Àü±â¿µµ¿, ½Å¼ÓÇÑ DNA ºÐ¼®, ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ(PCR), ÇÙ»ê Á¤Á¦ ¹× ÃßÃâ ±â¼úµµ Ȱ¿ëÇÕ´Ï´Ù. °³ÀÎ ½Äº°Àº ¹üÁËÀÚ ½Äº°, ÀÎü ÇüÁúÀÇ Àü¹ÝÀûÀÎ ºÐ¼®, ½ÇÁ¾ÀÚ ½Äº°, ÀüÀï Èñ»ýÀÚ ½Äº°, ÀçÇØ Èñ»ýÀÚ ½Äº°, »çÀÎ ¹× »ç¸Á ¹æ¹ý ½Äº° µî¿¡ ³Î¸® »ç¿ëµË´Ï´Ù. ¶ÇÇÑ °³ÀÎÀÇ ¹üÁË ±â·ÏÀ» ÃßÀûÇϰí ÈçÀûÀ» ÆÄ¾ÇÇÏ°í »ç¸éÀ» °áÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

°³ÀÎ ½Äº° ½ÃÀå µ¿Çâ :

¼¼°è ¹üÁËÀ² »ó½Â¿¡ µû¸¥ DNA °¨Á¤ ¼ö¿ä Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â Áß¿äÇÑ ¿ä¼Ò Áß ÇϳªÀÔ´Ï´Ù. ÀÌ¿¡ µû¶ó °³ÀÎ ½Äº°Àº °úÇÐ ¼ö»ç, ÀçÇØ ÇÇÇØÀÚ ½Äº°, ÀηùÇÐ µî¿¡¼­ ³Î¸® ÀÌ¿ëµÇ¸ç, À߸øµÈ Àι°À» ¹èÁ¦Çϰí, º¸´Ù ½ÇÇà °¡´ÉÇÑ ¼ö»ç ¼ö´Ü¿¡ ÀÚ¿øÀ» µ¹¸± ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´×(ML) ÅëÇÕ µî ¾ó±¼ Ư¡ ¸ÅÇÎ ¹× ±â·Ï, °íǰÁú ¼Ò½º »ùÇà ȹµæ, ½Ã½ºÅÛ È¿À² °³¼± µîÀ» Áö¿øÇÏ´Â ´Ù¾çÇÑ ±â¼úÀû Áøº¸°¡ ½ÃÀå ¼ºÀå ¿¡ ź·ÂÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½ÃÄö½Ì ±â¼úÀÇ ÃÖ±Ù µ¿ÇâÀº ¹ýÀÇÇÐ ¹× ºÎÀÚ °¨½Ã ½ÇÇè½Ç¿¡¼­ °³ÀÎ ½Äº°À»À§ÇÑ ¸ð¼¼°ü Àü±â ¿µµ¿(CE) ¹× ÃÊ º´·Ä ½ÃÄö½Ì(MPS) ¹æ¹ýÀÇ »ç¿ëÀ» °­È­Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÔ´Ï´Ù. ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ ±¤¹üÀ§ÇÑ R&D(R&D) Ȱµ¿°ú ¹ýÀÇÇÐ ÇÁ·Î±×·¥¿¡ ÀÚ±ÝÀ» Á¦°øÇϱâ À§ÇÑ ´Ù¾çÇÑ Á¤ºÎ Á¤Ã¥ÀÇ ±¸ÇöÀÌ ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ Àü¸ÁÀ» âÃâÇϰí ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

  • ¼¼°è °³ÀÎ ½Äº° ½ÃÀåÀº Áö±Ý±îÁö ¾î¶»°Ô ÃßÀÌÇϰí ÇâÈÄ ¾î¶»°Ô ÃßÀÌÇØ ³ª°¥ °ÍÀΰ¡?
  • COVID-19°¡ ¼¼°è °³ÀÎ ½Äº° ½ÃÀå¿¡ ¹ÌÄ£ ¿µÇâÀº?
  • ÁÖ¿ä Áö¿ª ½ÃÀåÀº?
  • Á¦Ç° ¹× ¼­ºñ½ºº° ½ÃÀå ºÐ¼®Àº?
  • ±â¼úº° ½ÃÀå ºÐ¼®Àº?
  • ¿ëµµº° ½ÃÀå ±¸¼ºÀº?
  • ÃÖÁ¾ »ç¿ëÀÚº° ½ÃÀå ±¸¼ºÀº?
  • ¾÷°èÀÇ ¹ë·ùüÀÎÀÇ ´Ù¾çÇÑ ´Ü°è¶õ?
  • ¾÷°èÀÇ ÁÖ¿ä ÃßÁø ¿äÀΰú µµÀüÀº ¹«¾ùÀΰ¡?
  • ¼¼°è °³ÀÎ ½Äº° ½ÃÀåÀÇ ±¸Á¶¿Í ÁÖ¿ä ÁøÃâ±â¾÷Àº?
  • ¾÷°è¿¡¼­ °æÀïµµ´Â?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»çÀÇ ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • »óÇâ½Ä Á¢±Ù
    • ÇÏÇâ½Ä Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

  • °³¿ä
  • ÁÖ¿ä ¾÷°è µ¿Çâ

Á¦5Àå ¼¼°èÀÇ °³ÀÎ ½Äº° ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ºÐ¼® : Á¦Ç°?¼­ºñ½ºº°

  • ±â±â
  • ºÐ¼® ŰƮ ¹× ½Ã¾à
  • ¼ÒÇÁÆ®¿þ¾î ¹× ¼­ºñ½º

Á¦7Àå ½ÃÀå ºÐ¼® : ±â¼úº°

  • ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ(PCR)
  • Â÷¼¼´ë ½ÃÄö½Ì(NGS)
  • ÇÙ»êÀÇ Á¤Á¦ ¹× ÃßÃâ
  • ¸ð¼¼°ü Àü±â ¿µµ¿
  • ½Å¼ÓÇü DNA ºÐ¼®
  • ±âŸ

Á¦8Àå ½ÃÀå ºÐ¼® : ¿ëµµº°

  • ¹ýÀÇÇÐ ¿ëµµ
  • Ä£ºÎ °¨Á¤
  • ±âŸ

Á¦9Àå ½ÃÀå ³»¿ª: ÃÖÁ¾ »ç¿ëÀÚº°

  • ¹ýÀÇÇÐ ¿¬±¸¼Ò
  • ¿¬±¸¼¾ÅÍ, Çмú±â°ü, Á¤ºÎ±â°ü

Á¦10Àå ½ÃÀå ³»¿ª: Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ºÐ¼® : ±¹°¡º°
    • ½ÃÀå ¿¹Ãø

Á¦11Àå SWOT ºÐ¼®

  • °³¿ä
  • °­Á¡
  • ¾àÁ¡
  • ±âȸ
  • À§Çù

Á¦12Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦13Àå Porter's Five Forces ºÐ¼®

  • °³¿ä
  • ±¸¸ÅÀÚÀÇ Çù»ó·Â
  • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
  • °æÀïµµ
  • ½Å±Ô ÁøÀÔ¾÷ÀÚÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦14Àå °¡°Ý ºÐ¼®

Á¦15Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Abbott Laboratories
    • Agilent Technologies Inc.
    • Bio-Rad Laboratories Inc.
    • Eurofins Scientific
    • Hamilton Company
    • Illumina Inc.
    • Laboratory Corporation of America Holdings
    • PerkinElmer Inc.
    • Promega Corporation
    • Qiagen NV
    • Siemens AG
    • Thermo Fisher Scientific Inc.
JHS 24.07.31

The global human identification market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.9 Billion by 2032, exhibiting a growth rate (CAGR) of 10.7% during 2024-2032.

Human identification refers to a technique used to analyze the deoxyribonucleic acid (DNA) sample for the identification of individuals and forensic investigation. It consists of body part detectors that assist in detecting lips, face, heads, shoulders, fingerprints, and palms. It also utilizes next-generation sequencing (NGS), capillary electrophoresis, rapid DNA analysis, polymerase chain reaction (PCR), nucleic acid purification, and extraction technologies. Human identification is widely used for criminal identification, overall analytics of human traits, identifying missing persons, casualties of war, disaster victims, and cause and manner of death. It also assists in tracking individual criminal record, identifying traces, and pardoning decisions.

Human Identification Market Trends:

The increasing demand for DNA analysis on account of rising criminal rates across the globe is one of the key factors driving the growth of the market. In line with this, human identification is widely used in forensics, disaster victim identification, and anthropology for eliminating wrongly associated individuals and redirecting resources to more viable avenues of investigation. Moreover, various technological advancements, such as the integration of artificial intelligence (AI) and machine learning (ML), that assists in mapping and recording facial features, obtaining high-quality source samples, and improving system efficiency, are providing an impetus to the market growth. Additionally, recent developments in sequencing technology have enhanced the utilization of capillary electrophoresis (CE) and massively parallel sequencing (MPS) methods for human identification in forensic and paternity testing labs, which, in turn, is positively impacting the market growth. Apart from this, extensive research and development (R&D) activities and the implementation of various government policies to provide funding for forensic programs are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global human identification market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product & service, technology, application and end user.

Breakup by Product & Service:

Instruments

Assay Kits and Reagents

Software and Services

Breakup by Technology:

Polymerase Chain Reaction (PCR)

Next Generation Sequencing (NGS)

Nucleic Acid Purification and Extraction

Capillary Electrophoresis

Rapid DNA Analysis

Others

Breakup by Application:

Forensic Applications

Paternity Testing

Others

Breakup by End User:

Forensic Laboratories

Research Centers, Academic and Government Institutes

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Eurofins Scientific, Hamilton Company, Illumina Inc., Laboratory Corporation of America Holdings, PerkinElmer Inc., Promega Corporation, Qiagen N.V., Siemens AG and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global human identification market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global human identification market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product & service?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global human identification market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Human Identification Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product & Service

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Assay Kits and Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Polymerase Chain Reaction (PCR)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Next Generation Sequencing (NGS)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Nucleic Acid Purification and Extraction
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Capillary Electrophoresis
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Rapid DNA Analysis
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Forensic Applications
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Paternity Testing
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Forensic Laboratories
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Research Centers, Academic and Government Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Agilent Technologies Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bio-Rad Laboratories Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Eurofins Scientific
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Hamilton Company
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Illumina Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Laboratory Corporation of America Holdings
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 PerkinElmer Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Promega Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Qiagen N.V.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Siemens AG
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦